Dr Reddy’s Laboratories launches Ropinirole Hydrochloride XR tablets

07 Jun 2012 Evaluate

Dr Reddy’s Laboratories has launched Ropinirole Hydrochloride XR (Extended Release) tablets (2mg, 4Mg, 6 mg, 8 mg and 12mg), a bioequivalent generic version of REQUIP XL tablets in the US market, following United States Food & Drug Administration (USFDA’s) approval for Dr Reddy’s ANDA for Ropinirole Hydrochloride XR (Extended Release).

The REQUIP XL brand has US sales of approximately $58 million for the most recent twelve months ending March 2012 according to the IMS Health.

Dr Reddy’s Ropinirole Hydrochloride XR (Extended Release) tablets (2mg, 4Mg, 6 mg, 8 mg and 12mg) are available in 30 and 90 count bottles sizes, 8 mg and 12 mg are available  in 30 count bottle sizes.

Dr. Reddys Lab Share Price

1270.00 4.05 (0.32%)
31-Dec-2025 14:41 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1270.00
Cipla 1508.00
Zydus Lifesciences 913.00
Lupin 2110.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×